T-cell research reveals paths to better vaccines for COVID-19 and beyond

New research on T-cells is unlocking why people infected with the same COVID-19 strain experience vastly different outcomes—from asymptomatic cases to severe illness requiring ventilators. T-cells are crucial immune cells that recognize and fight off pathogens, and understanding their response variations could transform vaccine design. This discovery opens doors to developing more effective vaccines not just for COVID-19, but for other infectious diseases as well. By tailoring vaccines to strengthen T-cell responses, researchers aim to create immunizations that provide better protection across diverse populations and genetic backgrounds.

Originally published on
Medical Xpress
Read full article(opens in new tab)Fetched: October 10, 2026 at 10:00 AM



